Facebook
Twitter
LinkedIn
ForwardTreatment and Management of Larynx Cancer (PRO 03)
This activity is comprised of a panel of radiation oncologists with a clinical practice focused on head and neck cancer. It includes two academic physicians as well as a community practitioner representing geographically different institutions. The activity is divided into early stage glottic carcinoma, locally advanced laryngeal cancer, and recurrent disease, discussing the role of radiation in both organ preservation and adjuvant settings, as well as salvage and palliative strategies. Also presented are key supportive management and survivorship issues unique to each situation, with follow-up recommendations. The activity integrates a series of clinical scenarios including fiberoptic nasolaryngoscopy videos and CT imaging, followed by a panel discussion.
Target Audience
This activity is designed to meet the interests of radiation oncologists and residents.
Learning Objectives
Upon completion of this live activity, participants should be better able to:
- Discuss treatment of larynx cancers for different stages of disease.
- Manage care of long-term survivors of larynx cancer.
Arshin Sheybani, MD, is employed by John Stoddard Cancer Center.
David J. Sher, MD, MPH, is employed by University of Texas Southwestern Medical Center. Dr. Sher receives research funding from Varian Medical Center.
Zain A. Husain, MD, is employed by Southern California Permanente Medical Group.
Gary V. Walker, MD, MS, MPH, is employed by Banner MD Anderson Cancer Center.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.25 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.